Want to join the conversation?
$ECL forecasts lower than expected growth in 4Q15, as the stronger external headwinds from unfavorable currency and the effect on its operations from devaluing Venezuelan bolivar business headwinds including pension, may impact earnings growth by 13 percentage points.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.